drugset

drugset / Trial / NCT06797999

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

NCT06797999 ↗

Phase 1/2 Recruiting 270 enrolled Adcendo ApS

NaSequentialOpen-labelTreatment

Summary

The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01.

Timeline

Start: 2025-06-05
Primary completion: 2029-02-27
Completion: 2029-02-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ADCE-D01	Unknown	—	—

Indications